MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of
available-for-sale securities
$8,990K
Net cash (used in)
provided by investing...
$5,654K
Canceled cashflow
$3,336K
Net decrease in
cash, cash...
$986K
Canceled cashflow
$4,668K
Purchases of
available-for-sale securities
$3,336K
Stock-based compensation
$1,410K
Prepaid expenses and
other current and...
-$603K
Depreciation expense
$243K
Non-cash lease expense
$69K
Net cash used in
operating activities
-$4,668K
Canceled cashflow
$2,325K
something is missing
$16,109K
Other income, net
$981K
Net loss
-$6,611K
Canceled cashflow
$17,090K
Accounts payable and
accrued liabilities
-$207K
Operating lease liability
-$105K
Amortization of premiums and
accretion of discounts on...
$70K
Loss from operations
-$23,701K
Total operating
expenses
$23,701K
Back
Back
Cash Flow
source: myfinsight.com
Athira Pharma, Inc. (ATHA)
Athira Pharma, Inc. (ATHA)